Financial targets, dividend policy and future outlook
Optomed’s medium-term, from 2020 onwards, target is to deliver a double digit annual organic revenue growth.
In the long-term Optomed’s target is to deliver an average annual organic revenue growth above 20 percent.
Optomed’s target in the medium-term is to prioritise investments in the organisation to support growth and achieve an adjusted EBITDA margin above 30% in the long-term.
Optomed is in expansion phase and will therefore prioritise growth over dividends in coming years.
Optomed expects the global market for handheld fundus cameras to develop favourably and believes that the increase in awareness of diabetic retinopathy supports the Devices and Software businesses. Optomed estimates that the growth for the full year 2019 to be low single digit growth, compared to 2018.